
“In our cohort, [diabetes mellitus] was a significant predictor of lower [erectile function recovery] at 2 years post-RP,” the authors wrote.

“In our cohort, [diabetes mellitus] was a significant predictor of lower [erectile function recovery] at 2 years post-RP,” the authors wrote.

International Index of Erectile Function-Erectile Function (IIEF-EF) score increased in patients receiving nutraceuticals.

Investigators found that about one-fourth of men who underwent the “testosterone challenge” had a rise in PSA level.

Neoadjuvant chemotherapy significantly benefited patients with classifier-identified non-luminal tumors.

"For patients who can maintain a functional implant in-situ, long-term patient satisfaction rates remain high," said Elodie Beels, MD.

In a recent study, investigators sought to understand the current viewpoints of the general population on testicular cancer and testicular self-examination.

By identifying trends in race and ethnicity of academic urologists, this study poses as an opportunity for future intervention.

Michael A. Palese, MD, weighs in on the stigmas associated with robotic surgery.

"We believed that the drug would work as well in OAB wet as it did in OAB dry, so we're pleased to see that it was statistically significantly better than placebo at the 12-week point for looking at response to both metrics in both group," says David Staskin, MD.

"I think another good take-home message is the importance of the informed consent process," says Una Lee, MD.

"As a committee, we felt that there was a need to put together a document to help field some of the ethical considerations that we run into in clinical care but have very little guidance on," says Anne M. Suskind, MD, MS, FACS, FPMRS.

"The perceived stigma that this population is promoting antibiotic resistance is not the patient’s fault. It's our responsibility as physicians and urologists to find the answers for our patients," said J. Curtis Nickel, MD.

In a recent Journal of Urology study, Jordan J. Kramer, MD, and co-authors examined whether statins impact LUTS incidence in asymptomatic men and progression in symptomatic men with BPH.

In an effort to destigmatize urinary incontinence, Jai Seth, MD, discusses why it is important to educate the general public about this medical condition so that it can be normalized rather than stigmatized.

“Our study provides important findings that help to address the lack of data in Black/African American patients who are disproportionally affected by prostate cancer,” said Neal D. Shore, MD.

Active surveillance is no longer the preferred management strategy for low-risk prostate cancer, according to the updated NCCN guideline.

2 recent studies highlighted the continued emergence of liquid biopsies. One study involved bladder cancer and the other involved peripheral nerve tumors, which in rare cases occur in the prostate.

To examine the disparities of ED diagnosis and referral, Denise Asafu-Adjei, MD, MPH, and a team of investigators conducted a study involving 2 outpatient urology settings who serve communities with varying demographics.

In a recent study presented at the 2021 AUA Annual Meeting, Scarlett Gomez, MPH, PhD, and co-authors investigated the determinants of selecting active surveillance/watchful waiting as a treatment path for patients with localized, low-risk prostate cancer.

Senior author Peter N. Schlegel, MD, FACS, recently presented updates to the AUA/ASRM guideline for the diagnosis and treatment of infertility in men at the 2021 AUA Annual Meeting.

“The goals of [this phase of the] trial were to confirm system performance, to evaluate patient compliance, and to determine daily stimulation duration,” said Dr. Steven W. Siegel.

In a study presented at the 2021 AUA annual meeting, Behfar Ehdaie, MD, MPH, and colleagues assessed the efficacy of focal therapy in treating patients with grade group 2 or 3 prostate cancers.

Daytime incontinence decreased in two-thirds of participants who performed core stability exercises.

Dharam Kaushik, MD, and a team of investigators are the first to examine the benefits of perioperative yoga in patients diagnosed with localized prostate cancer.

In a recent study presented at the 2021 AUA Annual Meeting, Laurence Klotz, MD, FRCSC, and a team of investigators determined the accuracy of the new miR Sentinel PCC4 Test, a urinalysis of low- to high-grade prostate cancer in men.

Moderate physical activity and a greater time spent participating in moderate physical activity was associated with a decreased likelihood of stress, urge and mixed urinary incontinence in women.

"What will probably be surprising to the reader is that patients managed in markets with higher average prices for prostatectomy were not more likely to undergo treatment," says Lillian Y. Lai, MD.

In a study presented at the 2021 AUA Annual Meeting, Karim Chamie, MD, and coauthors further examine the long-term results of UGN-101 for patients with LG UTUC given the favorable outcomes of the initial OLYMPUS trial.

Mathew D. Sorensen, MD, MS, FACS, and a team of investigators recently assessed the efficacy and safety of ultrasonic propulsion treatment on patients with kidney stones.

In a recent study presented at the 2021 AUA Annual Meeting, Naeem Bhojani, MD, FRCSC, David-Dan Nguyen, and co-authors reported the favorable 3-year results of ongoing Aquablation research specifically involving patients with large prostates.